Valuation: Boule Diagnostics AB

Market Cap 126M 13.33M 11.42M 10.68M 9.78M 18.35M 1.28B 18.59M 49.22M 641M 50.04M 48.96M 2.12B P/E 2026 *
-12.9x
P/E 2027 * 14.7x
Enterprise Value 323M 34.08M 29.2M 27.32M 25.01M 46.93M 3.26B 47.55M 126M 1.64B 128M 125M 5.42B EV / Sales 2026 *
0.71x
EV / Sales 2027 * 0.64x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 day-0.91%
1 week-6.61%
Current month-14.92%
1 month-3.56%
3 months-3.85%
6 months-18.75%
Current year-33.81%
1 week 3.23
Extreme 3.23
3.48
1 month 3.23
Extreme 3.23
3.95
Current year 2.75
Extreme 2.75
5.68
1 year 2.75
Extreme 2.75
6.64
3 years 2.75
Extreme 2.75
12.62
5 years 2.75
Extreme 2.75
60
10 years 2.75
Extreme 2.75
108.88
Manager TitleAgeSince
Chief Executive Officer - 21/06/2026
Director of Finance/CFO 54 10/02/2026
Chief Tech/Sci/R&D Officer - 31/12/2018
Director TitleAgeSince
Director/Board Member 59 31/12/2013
Chairman 73 31/12/2020
Chairman 74 31/12/2022
Date Insider Type Main position Quantity % Market Cap.
27/02/23 Buy

Chief Financial Officer

8,000 0.0206%
06/02/23 Buy

Director

7,083 0.0182%
17/02/22 Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-0.91%-6.61%-47.58%-64.64% 13.33M
+0.27%+6.97%+25.86%+19.39% 233B
+1.36%+8.10%+3.33%-12.35% 154B
+1.16%-3.98%-20.44%+31.92% 134B
+2.03%-2.82%-52.56%-0.08% 73B
+0.98%+2.26%-16.22%-12.49% 52.24B
-0.04%-1.98%+9.73%+18.19% 51.75B
+1.73%+7.05%+30.72%+35.16% 44.91B
+1.49%-0.36%+35.91%+53.26% 40.35B
+1.03%+1.53%-0.53%+8.54% 33.8B
Average +0.91%+0.92%-3.18%+7.69% 81.64B
Weighted average by Cap. +0.98%+3.00%+2.97%+13.70%

Financials

2026 *2027 *
Net sales 453M 47.85M 40.99M 38.35M 35.11M 65.89M 4.58B 66.76M 177M 2.3B 180M 176M 7.61B 483M 51.04M 43.72M 40.91M 37.45M 70.28M 4.88B 71.21M 188M 2.45B 192M 187M 8.11B
Net income -9.77M -1.03M -884K -827K -757K -1.42M -98.75M -1.44M -3.81M -49.61M -3.88M -3.79M -164M 8.6M 908K 778K 728K 666K 1.25M 86.86M 1.27M 3.35M 43.63M 3.41M 3.33M 144M
Net Debt 197M 20.76M 17.78M 16.64M 15.23M 28.58M 1.99B 28.96M 76.65M 998M 77.94M 76.24M 3.3B 185M 19.49M 16.69M 15.62M 14.3M 26.83M 1.86B 27.18M 71.96M 937M 73.17M 71.57M 3.1B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
21/08/26 SEK 3.250 -0.91% 23,706
20/08/26 SEK 3.280 -0.91% 3,683
19/08/26 SEK 3.310 +0.30% 42,875
18/08/26 SEK 3.300 -2.94% 29,955
17/08/26 SEK 3.400 -2.30% 24,509
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.250SEK
Average target price
3.800SEK
Spread / Average Target
+16.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock